Azacitidine
NDC 75907-225, Azacitidine, injection, powder, lyophilized, for solution, from Dr. Reddy's Laboratories Inc..
- Product NDC
- 75907-225
- Status
- Listed
- Labeler
- Dr. Reddy's Laboratories Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201537
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75907-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZACITIDINE100 mg/1
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75907-225-11 | 75907022511 | 1 VIAL in 1 CARTON (75907-225-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/060d56e7-1a24-87c1-7f40-149ecf424f7cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=75907-225
Use it
Look up 75907-225 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75907-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75907-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.